COPENHAGEN (Reuters) - Denmark's Novo Nordisk lifted third-quarter core profit by 40 percent and above expectations on the back of strong sales of diabetes drug Victoza and modern insulins.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here.. For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/10/novo-nordisk-raises-year-view-after-q3_31.html
No comments:
Post a Comment